POZIATS Report – Hospital 175

On the morning of July 22, 2019, CPDP Medbolide Company had a scientific report session at the Department of Neurology (7A) Hospital 175, introducing the product POZIATS (Aripiprazole 5mg/10mg) with the participation of Dr. Hoang Tien Trung Nghia (Department Head) and 25 treating doctors.

The representative of Medbolide Company introduced the novelty, effectiveness, wide spectrum of indications and safety of the active ingredient Aripiprazole and the competitive advantage of the product Poziats. NCLS on the difference of Aripiprazole in improving bipolar disorder, autism, depression, schizophrenia, Tourette syndrome and alcohol and substance abuse psychosis compared to antipsychotic active ingredients Other gods have also been presented.

Doctors and Company representatives had further discussions regarding the dosage of each indication and the mechanism of action of the active ingredient according to the dose. At the end of the report, Medbolide Company sends its thanks and hopes to continue accompanying the Department of Neurology in bringing solutions to improve the quality of life for patients.